Pfizer Financial Results

Pfizer Q2 FY27 Results: Net Profit ₹313.2 Cr, Up 65.7% YoY

Pfizer Limited reported unaudited financial results for the quarter ended September 30, 2026. The company recorded a net profit of Rs. 313.25 Crore on total income of Rs. 774.19 Crore.

Key figure

Net profit ₹313.2 Cr · +65.7% YoY

Pfizer Board Meeting Date

Pfizer Limited has scheduled a board meeting for 3 November 2026 to consider unaudited standalone half-yearly results for the period ended September 2026. The trading window closes from 30 September 2026 until 5 November 2026.

Pfizer Other Announcement

Pfizer Ltd has filed its quarterly shareholding pattern as per SEBI regulations. This is a routine compliance disclosure.

Pfizer Legal & Regulatory

Pfizer Limited received a penalty order of Rs. 1.26 Crore from the Income Tax department regarding transfer pricing. The company plans to appeal the order and expects no material financial impact.

Value

₹1.26 Cr

From

Deputy / Additional Commissioner of Income tax Transfer Pricing

Pfizer Management Change

Pfizer Limited announced the resignation of Mr. Sharad Goswami, Senior Director – Policy & Public Affairs, effective from the close of business on September 25, 2026.

Pfizer Board Meeting Outcome

Pfizer Board approved discontinuation of Minipress XL effective September 7, 2026. The company will receive ₹131.38 Crore lump-sum payment from Pfizer Inc., USA.

Value

₹131.4 Cr

Velox Shipping and Logistics Q2 FY27 Results: Net Profit ₹0.8 Cr, Up 166.7% YoY

Velox Shipping and Logistics Ltd reported revenue from operations of ₹2.5 Cr and net profit of ₹0.8 Cr (+166.7% YoY) for Q2 FY27.

Key figure

Net profit ₹0.8 Cr · +166.7% YoY

Ecofinity Atomix Q2 FY27 Results: Net Profit ₹0.7 Cr, Up 16.7% YoY

Ecofinity Atomix Ltd reported revenue from operations of ₹26.5 Cr (+145.4% YoY) and net profit of ₹0.7 Cr (+16.7% YoY) for Q2 FY27.

Key figure

Net profit ₹0.7 Cr · +16.7% YoY

Transglobe Foods Q2 FY27 Results: Net Profit ₹0 Cr

Transglobe Foods reported unaudited Q2 and H1 FY27 results for the period ended 30 September 2026. The half-year net loss was ₹3.49 lakhs, with going-concern doubts noted.

Key figure

Net profit ₹0 Cr

Euro India Fresh Foods Q2 FY27 Results: Turns Profitable, Net Profit ₹0.1 Cr

Euro India Fresh Foods Ltd reported revenue from operations of ₹29.9 Cr (-8.0% YoY) and net profit of ₹0.1 Cr for Q2 FY27.

Key figure

Net profit ₹0.1 Cr

Market Creators Q2 FY27 Results: Turns Profitable, Net Profit ₹0.1 Cr

Market Creators Ltd reported revenue from operations of ₹1.4 Cr (+16.7% YoY) and net profit of ₹0.1 Cr for Q2 FY27.

Key figure

Net profit ₹0.1 Cr

Sharma East India Hospitals & Medical Research Q2 FY27 Results: Net Profit ₹0.3 Cr, Up 0.0% YoY

Sharma East India Hospitals & Medical Research Ltd reported revenue from operations of ₹10.4 Cr (+10.6% YoY) and net profit of ₹0.3 Cr (+0.0% YoY) for Q2 FY27.

Key figure

Net profit ₹0.3 Cr · +0.0% YoY